Latest Study on “Next-Generation Sequencing Data Analysis Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030”.
Latest Study on “Next-Generation Sequencing Data Analysis Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030”.
The global Next-Generation Sequencing Data Analysis market size is expected to be worth around USD 2.4 billion by 2030, according to a new report by Nova one advisor.
The global Next-Generation Sequencing Data Analysis market size was valued at USD 547.1 million in 2021 and is anticipated to grow at a CAGR of 13.9% during forecast period 2022 to 2030.
Request Free Sample of This Report@ https://www.novaoneadvisor.com/report/sample/7367
The growth can be attributed to a significant decline in the cost of NGS installation in clinical diagnosis. Furthermore, the accessibility of genomic and proteomic data is anticipated to create significant growth opportunities. In addition, a reduction in the cost of sequencing is anticipated to boost the adoption rate of NGS, which would further drive the industry. The availability of tools, such as the Targeted Methyl-Seq platform and Agilent’s HaloPlex capture system from EpiGentek Group Inc. has aided in the DNA methylation profiles determination in individual genomes. The COVID-19 pandemic has enhanced NGS usage and has created a huge demand.
The NGS tools can generate a significant amount of data for scientists to analyze and study pathogenesis. Researchers from industry, academia, and government have used data analysis technology to help in understanding the characteristics, phylogenetics, and processes of SARS-CoV2. NGS technologies have helped to unveil biological information that has not been studied yet using conventional technologies. For instance, NGS has helped study genomic patterns associated with various biological processes and epigenomics. However, issues related to accessing storage management, and analysis of data are anticipated to offer huge R&D prospects, thus, driving the industry growth. Researchers that use high-throughput sequencers demand software systems, such as Laboratory Information Management Systems (LIMS) to archive and handle sequencing information.
Furthermore, the introduction of workflow management system solutions, such as Galaxy and Chipster, drives demand for technological advancements in data storage and management. Demand for technologically advanced infrastructure to monitor the flow of data analysis process from data generation to preliminary analysis to higher-level analysis has increased. Moreover, NGS data analysis tools are being constantly upgraded for obtaining effective results and higher utility. For instance, in December 2021, Bionano Genomics launched BioDiscovery’s NxClinical Software Version 6.1 for genome analysis. The version enables enhanced visualization and interpretation of NGS data for cancer and genetic disease domains. Such developments are anticipated to drive the industry over the forecast period.
Report Scope of the Next-generation Sequencing Data Analysis Market
|
Report Coverage |
Details |
|
Market Size |
USD 2.4 Billion by 2030 |
|
Growth Rate |
CAGR of 13.9% from 2022 to 2030 |
|
Largest Market |
North America |
|
Fastest Growing Market |
Asia Pacific |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2030 |
|
Segments Covered |
Product, workflow, mode, end-use, read length and Region, |
Key Takeaways:
- The services product segment dominated the industry in 2021. NGS has several advantages, in terms of speed and affordability, and many research institutes are unable to adopt it due to a lack of skilled professionals and sufficient computational infrastructure
- The tertiary analysis workflow segment captured the major revenue share in 2021 as it accounts for the complex and important step of NGS, which is linked with the interpretation of the results
- The in-house mode segment dominated the market in 2021 and is anticipated to remain dominant in the coming years. However, the outsourced mode segment is anticipated to witness the fastest growth rate from 2022 to 2030 owing to time and cost advantages
- The short-read sequencing segment held the maximum share in 2021 due to the high adoption of short-read sequencing techniques and their cost-effective nature & ability to work with DNA fragments and the availability of several tools & algorithms
- The academic research end-use segment dominated the market in 2021. A reduction in the NGS technology cost has fueled the NGS software platforms usage by several research centers & academic institutions for their research that require data interpretation
- North America captured the highest revenue share in 2021 owing to the presence of well-developed information technology companies, favorable reimbursement network, and high government funding and high public & private expenditures in the biotechnology sector
Ask here for more customization study@ https://www.novaoneadvisor.com/report/customization/7367
Regional Insights
North America dominated the global industry in 2021 and accounted for the maximum share of more than 49.8% of the global revenue. This is owing to the significant advancements in personalized medicine, companion diagnostics, and NGS. Moreover, growing emphasis on process optimization & reducing costs, and decreasing overall turnaround time for clinical processes are projected to create lucrative growth opportunities for the industry. These fields are capital-intensive, and hence require high R&D investment. in January 2020, Illumina Inc., entered into a multi-year partnership with ArcherDx, Inc. to expand access to NGS-based oncology testing along with companion diagnostics for the selection of therapeutics and personalized monitoring.
The Asia Pacific region is anticipated to witness the fastest growth rate during the forecast period. Several genomic programs are initiated in this region that focuses on integrating genomics into healthcare, consequently utilizing NGS technologies. For instance, The Australian Genomics or Australian Genomics Health Alliance is a collaborative research partnership of more than 80 organizations that aims at integrating genomics into healthcare. Furthermore, several advancements by companies are expected to enhance the availability of NGS technologies and associated software in this region. In March 2022, Vela Diagnostics launched NGS-based panels, Comprehensive (525 Genes) and Focused (60 Genes), that could detect RNA and DNA biomarkers.
Some of the prominent players in the Next-generation Sequencing Data Analysis Market include:
- Golden Helix, Inc.
- Bio-Rad Laboratories, Inc.
- SciGenom Labs Pvt. Ltd.
- DNAnexus Inc.
- Genuity Science
- Fabric Genomics, Inc.
- Congenica Ltd.
- QIAGEN
- DNASTAR, Inc.
- Pacific Biosciences of California, Inc.
- Eurofins Scientific
- Partek Incorporated
- Precigen Bioinformatics Germany GmbH
- PierianDx
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Illumina, Inc.
- Verily Life Science
- Thermo Fisher Scientific, Inc.
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Next-generation Sequencing Data Analysis market
- Product
- Services
- NGS Commercial Software
- Platform OS/UI
- Analytical Software
- QC/Pre-processing Tools
- Alignment Tools & Software
- DNA Sequencing Alignment
- RNA Sequencing Alignment
- Protein Sequencing Alignment
- Others
- Workflow
- Primary
- Secondary
- Read Mapping
- Variant Alignment & Variant Calling
- Tertiary
- Variant Annotation
- Application Specific
- Targeted Sequencing/Gene Panel
- Exome
- RNA Sequencing
- Whole Genome
- Chip Sequencing
- Others
- Mode
- In-house
- Outsourced
- Read Length
- Short Read Sequencing
- Long Read Sequencing
- Very Long Read Sequencing
- End-use
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Other Users
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Full Report is Ready | For Purchase Inquiry@ https://www.novaoneadvisor.com/report/checkout/7367
You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
Blog: https://qyresearchmedical.com/